Novelty in Clinical Medicine (Aug 2022)

Antibacterial Activity of Modified Carvacrol against Staphylococcus epidermidis and Pseudomonas aeruginosa

  • Mona Ghod Elahi,
  • Malak Hekmati,
  • Davoud Esmaeili,
  • Parisa Ziarati,
  • Mohamad Yousefi

DOI
https://doi.org/10.22034/ncm.2022.350997.1051
Journal volume & issue
Vol. 1, no. 4
pp. 192 – 196

Abstract

Read online

Background: Carvacrol is the main phenolic compound of Satureja and thyme. Carvacrol has antibacterial, antifungal, anti-inflammatory, and anti-cancer properties.Objectives: The aim of this study is determine the peptide-modified carvacrol’s antibacterial effects against Staphylococcus epidermidis and Pseudomonas aeruginosa.Methods: The peptide-modified carvacrol’s antibacterial activity against Staphylococcus epidermidis and Pseudomonas aeruginosa was investigated by disk diffusion and MIC method.Results: The effects of modified carvacrol by the disk diffusion method had growth inhibition diameters of 25mm and 20mm against Staphylococcus epidermidis and Pseudomonas aeruginosa, respectively. Also, MIC against Staphylococcus epidermidis and Pseudomonas aeruginosa was 1µg/ml and 0.51µg/ml, respectively.Conclusion: The peptide-modified carvacrol has some antibacterial effects.

Keywords